Chest Medicine
Updated CDC Guidance: How COVID-19 Spreads
6 Oct, 2020 | 00:59h | UTCHow COVID-19 Spreads – Centers for Disease Control and Prevention
Commentary: CDC revises coronavirus guidance to acknowledge that it spreads through airborne transmission – CNBC
Long-term health consequences of COVID-19
6 Oct, 2020 | 00:58h | UTCLong-term Health Consequences of COVID-19 – JAMA
Commentary on Twitter
Persistent post-COVID symptoms could be the from direct tissue invasion by the virus, profound inflammation & cytokine storm, related immune system damage, hypercoagulable state, or some combination https://t.co/G8tI9U3TaL @CarlosdelRio7 lfcollins_md @PreetiNMalani
— JAMA (@JAMA_current) October 5, 2020
Meta-analysis: Risk of venous thromboembolism in patients with COVID‐19
6 Oct, 2020 | 00:54h | UTC
Commentaries on Twitter
In a new #RPTH paper, researchers performed a meta-analysis of #VTE risk in #COVID19 patients: 22.7% prevalence in ICU vs. 7.9% in non-ICU patients. Other subgroup analyses reveal heterogeneity and interesting trends…@Cihan_Ay_MD @FlorianMoik NEW: https://t.co/24IWOm5qTe pic.twitter.com/HjnSYq9YKz
— RPTH (@RPTHjournal) September 30, 2020
Meta-analysis of #clotting events in 66 studies including 28173 patients with #COVID19. High #VTE & #PE prevalence in ICU patients indicates a need for thromboprophylaxis research! Read the results at #RPTH by @Cihan_Ay_MD @FlorianMoik https://t.co/24IWOlNPuE @thrombosisday pic.twitter.com/V4Pn2ssBH3
— RPTH (@RPTHjournal) October 5, 2020
What we have found was a trend of decreased VTE rates over time. Earlier studies reported slightly higher VTE rates than more recent ones. What could be the reason? Experience dealing with COVID19 and improved preventive strategies? https://t.co/YDjRyvNmK6 https://t.co/y3Uj5x3QRI pic.twitter.com/0HcFQvMJB8
— Cihan Ay (@Cihan_Ay_MD) September 26, 2020
A ‘herd mentality’ can’t stop the COVID-19 pandemic. Neither can a weak vaccine
6 Oct, 2020 | 00:53h | UTC
Systematic review: Sublingual immunotherapy for asthma
6 Oct, 2020 | 00:11h | UTCSublingual immunotherapy for asthma – Cochrane Library
Summary: Sublingual immunotherapy for asthma – Cochrane Library
Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection
4 Oct, 2020 | 23:36h | UTCCommentary: Mysterious inflammatory syndrome tied to COVID-19 strikes adults as well as kids – Live Science
Commentary on Twitter
A new @CDCMMWR finds that adults who had #COVID19 can develop a condition similar to multisystem inflammatory syndrome in children and have severe outcomes including requiring intensive care. Learn more: https://t.co/dU1tS85Sj3. pic.twitter.com/RitCzJsLTL
— CDC (@CDCgov) October 2, 2020
Study: Four out of five people with sudden loss of smell or taste had COVID-19
4 Oct, 2020 | 23:30h | UTCCommentaries: Coronavirus: Loss of smell may be clearer sign than cough – BBC AND Coronavirus: Four out of five with sudden loss of smell or taste had COVID-19, study finds – Sky News
Commentary on Twitter
Four out of five people who experienced sudden loss of smell or taste had #COVID19, in a study by @ProfBatterhamMD and colleagues @ucl and @uclh #SARSCoV2
🔎 @PLOSMedicine paper: https://t.co/MoGTowbPus
📰 @SkyNews article: https://t.co/qgZJt9NHk6— PLOS (@PLOS) October 2, 2020
Perspective: What we know about vitamin D and Covid-19 (spoiler: not much)
4 Oct, 2020 | 23:28h | UTCWhat We Know About Vitamin D and Covid-19 – Medium
Editorial: COVID ARDS is not different from ARDS of other causes. Patients should be managed according to the evidence-based recommendations for non COVID related ARDS.
4 Oct, 2020 | 23:23h | UTC
Commentary on Twitter
#COVID19 #ARDS? after careful bedside physiological assessment, we may state #SARSCoV2 pts may be managed according to evidence-based recommendations for non COVID related ARDS@audreydejongMD @oriolrocag https://t.co/71TqeTJXMW
On @cafeoranestesia et al https://t.co/FZS2oGm30D pic.twitter.com/HJQ4FLCuL2
— Intensive Care Medicine (@yourICM) October 3, 2020
Evaluation of oxygenation in 129 proning sessions in 34 mechanically ventilated COVID-19 patients
4 Oct, 2020 | 23:24h | UTC
ASH 2020 guidelines for the management of deep vein thrombosis and pulmonary embolism
4 Oct, 2020 | 23:12h | UTC
Video: Are “superspreaders” the key to stopping COVID?
2 Oct, 2020 | 09:31h | UTCAre “Superspreaders” The Key To Stopping COVID? – ZDoggMD Show
Related: This Overlooked Variable Is the Key to the Pandemic. It’s not R. – The Atlantic
Large study highlights the role of super-spreaders in Covid-19 transmission
2 Oct, 2020 | 09:32h | UTCEpidemiology and transmission dynamics of COVID-19 in two Indian states – Science
Commentaries: Largest COVID-19 contact tracing study to date finds children key to spread, evidence of superspreaders – Princeton University AND Largest study of COVID-19 transmission highlights essential role of super-spreaders – Los Angeles Times AND Huge Study of Coronavirus Cases in India Offers Some Surprises to Scientists – The New York Times
Commentary on Twitter
🚨Large study of >500,000 people in #India exposed to the #coronavirus found:
▶️Viral spread is driven by a small % of "superspreaders"
▶️Children & young adults are much more important to viral spread—especially within households—than previously reportedhttps://t.co/GziQHVixfL— Dena Grayson, MD, PhD drdenagrayson.bsky.social (@DrDenaGrayson) October 1, 2020
What does it mean if a vaccine is ‘successful’?
2 Oct, 2020 | 09:25h | UTCWhat Does It Mean If a Vaccine Is ‘Successful’? – Wired
‘Provocative results’ boost hopes of antibody treatment for COVID-19
2 Oct, 2020 | 09:21h | UTC‘Provocative results’ boost hopes of antibody treatment for COVID-19 – Science
Randomized trial: Hydroxychloroquine vs. placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers
1 Oct, 2020 | 09:17h | UTCCommentary: Hydroxychloroquine didn’t prevent COVID-19 among health care workers in new study – CNN
Commentary on Twitter
#Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infection, in a double-blind randomized placebo-controlled trial performed at 2 University of Pennsylvania hospitals https://t.co/7XHn6uBh4Z
— JAMA Internal Medicine (@JAMAInternalMed) September 30, 2020
Recommendations for antibacterial therapy in adults with COVID-19 – An evidence based guideline
1 Oct, 2020 | 09:15h | UTC
Commentary on Twitter
🔥Just published🔥@CMIJournal
Recommendations for antibacterial therapy in adults with COVID-19 – An evidence based guideline by the Dutch Working Party on Antibiotic Policy. #IDTwitter #COVID19 https://t.co/7cfZtS6Duv pic.twitter.com/Kz7CPMNLmh— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) September 30, 2020
[Abstract Only] Atezolizumab for first-line treatment of PD-L1–selected patients with non–small-cell lung cancer
1 Oct, 2020 | 08:53h | UTCCommentary: Atezolizumab Leads to Longer OS for Some Types of Advanced NSCLC, Study Says – AJMC
New COVID-19 inpatient risk calculator estimates the probability of severe disease or death at hospital admission
30 Sep, 2020 | 09:51h | UTCCommentaries: COVID-19 ‘prediction model’ uses data that can help determine if patients’ conditions are likely to worsen – Johns Hopkins Medicine AND Prediction model incorporates more than 20 variables at hospital admission – Physician’s Weekly AND Patient Trajectories Among COVID-19 Hospitalized Patients – American College of Cardiology
Interactive Calculator: The COVID Inpatient Risk Calculator: CIRC
Commentary on Twitter
Lead authors Brian T. Garibaldi, MD, MEHP and Jacob Fiksel, PhD of @HopkinsMedicine developed the COVID-19 Inpatient Risk Calculator (CIRC) that uses patient data at admission to determine potential disease trajectory for #COVID19.
Link: https://t.co/i1e1ek7wO7. @Bedsidemedicine pic.twitter.com/wQLctHHYrn
— Annals of Int Med (@AnnalsofIM) September 22, 2020
Proposed clinical criteria for COVID-19-associated hyperinflammatory syndrome
30 Sep, 2020 | 09:50h | UTC
Commentary on Twitter
Defining and grading the clinical hyperinflammatory syndrome with #COVID19 and how this cytokine storm relates to outcomes https://t.co/6Ngp3OHZJx @TheLancetRheum @Intermountain pic.twitter.com/bDGwKpjOI4
— Eric Topol (@EricTopol) September 29, 2020
IDSA updated guidelines on the treatment of patients with COVID-19
28 Sep, 2020 | 01:40h | UTC
Commentary on Twitter
.@IDSAInfo has updated its #COVID19 treatment guidelines:
*Don't give #tocilizumab
*Give #dexamethasone but not if room air oxygen saturation is > 94%https://t.co/66nwQQZgsz pic.twitter.com/PQNAaFBZS4— Mike Stevens (@Dr_Mike_Stevens) September 26, 2020
Coronavirus update with Anthony S. Fauci, MD
28 Sep, 2020 | 01:37h | UTCCoronavirus Update With Anthony S. Fauci, MD – September 25, 2020 – JAMA
Changing age distribution of the COVID-19 pandemic in the US
28 Sep, 2020 | 01:36h | UTCCommentaries: Younger Americans Are Eclipsing Older Age Groups in COVID-19 Case Counts – TIME AND By August, 1 in 5 Covid-19 cases was someone in their 20s – CNN
Commentary on Twitter
Study showing that an increase in #COVID19 cases in young adults in the US preceded an increase in cases in those aged 60 years and older by an average of 9 days.
Infections in young people are important. The virus does not stay in this age group.https://t.co/TWIGS1Rg8A pic.twitter.com/tgr4xMzTe2
— Dr Zoë Hyde (@DrZoeHyde) September 26, 2020
ECMO in Covid-19: An international cohort
28 Sep, 2020 | 01:33h | UTC
Small randomized trial evaluated intravenous methylprednisolone pulse as a treatment for hospitalized severe COVID-19 patients
25 Sep, 2020 | 02:41h | UTC


